• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of CYP2D6 gene haplotype in patients of juvenile onset Parkinson disease

Research Project

Project/Area Number 06670658
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Neurology
Research InstitutionKYUSHU UNIVERSITY

Principal Investigator

FURUYA Hirokazu  Kyushu Univ. Medicine lecturer, 医学部, 助手 (60253415)

Project Period (FY) 1994 – 1995
Project Status Completed (Fiscal Year 1995)
Budget Amount *help
¥2,200,000 (Direct Cost: ¥2,200,000)
Fiscal Year 1995: ¥400,000 (Direct Cost: ¥400,000)
Fiscal Year 1994: ¥1,800,000 (Direct Cost: ¥1,800,000)
KeywordsParkinson disease / Cytochrome P450 / polymorphism / haplotype analysis / debrisoquine hydroxylase (CYP2D6) / CytochromeP450 / debrisoquine hydroxylase (CYP2D6) / Cytochrome P450 / Parkinson disease(Juvenile onset) / PCR
Research Abstract

Juvenile onset Parkinson disease (YOPD) is one of subtype of Parkinson disease (PD), but its onset age of symptom is below 40 and some cases have a genetic background. Since its symptoms are homogenous, it is considered to be suitable for analysis of genetic background. Cytochrome P450 debrisoquine hydroxylase (CYP2D6) has been regarded as one of the main genetic factor in PD.So, we analyze relationships between YOPD and CYP2D6 by determing haplotype of CYP2D6 gene polymorphisms.
Genomic DNA samples are extracted from 8 YOPD, 18 PD and 55 age matched normal control. The B mutation in CYP2D6 are detected with the method by Smith et al and Hha I RFLP in exon 6 by Tuneoka et al. In Caucasian populatiopn, it is reported that the frequency of B mutation homozygous genotype (poor metabolizer of debrisoquine hydroxylase) is quite high in PD.But on the contrary, we found that its frequency is quite low in Japanese population and is not useful for genetic marker.
Next, we use Hha I RFLP, which is rather high frequency in Japanese population. In conclusion, there is no mutation homozygous type, which is reported to be rather high frequency in Caucasian PD, is not found in Japanese YOPD and PD sample. Furthermore, there are no different allele frequency of Hha I RFLP between YOPD, PD and normal control. These results indicate that there is a possibility that CYP2D6 is not the risk factor of PD or YOPD.

Report

(3 results)
  • 1995 Annual Research Report   Final Research Report Summary
  • 1994 Annual Research Report
  • Research Products

    (8 results)

All Other

All Publications (8 results)

  • [Publications] Yokota H: "cDNA cloning and chromosome mapping of human dihydropyrimidine dehydrogenase, an enzyme associated with 5-fluorouracil toxicity and congenital thymine uraciluria" J Biol Chem. 269. 23192-23196 (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Yasutake T: "Molecular analysis of X-linked adrenoleukodystrophy patients" J Neurol Sci. 131. 58-64 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Furuya H: "Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy" Pharmacogenetics. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Yokota H, Fernandez-Salguero P, Furuya H, et al.: "cDNA cloning and chromosome mapping of human dihydropyrimidine dchydrogenase, an enzyme associated with 5-fluorouracil toxicity and congenital thymine uraciluria." J Biol Chem. 269. 23192-23196 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Yasutake T, Yamada T, et al.: "Molecular analysis of X-linked adrenoleukodystrophy patients." J Neurol Sci. 131. 58-64 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Furuya H, Fernandez-Salguero P, et al.: "Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy." Pharmacogenetics. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Yasutaka T: "Molecular analysis of X-linked adrenoleukodystrophy patients" J Neurol Sci. 131. 58-64 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] Furuya H: "Genetic polymorphism CYP2C9 and its effect on warfarin maintenance dose repuirement in patients undergoing anticoagulation therapy" Pharmacogenetics. (in press).

    • Related Report
      1995 Annual Research Report

URL: 

Published: 1994-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi